Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Sells $504,900.00 in Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRAGet Free Report) Director Lori Anne Kunkel sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, July 6th. The stock was sold at an average price of $50.49, for a total value of $504,900.00. Following the transaction, the director directly owned 41,884 shares in the company, valued at $2,114,723.16. This trade represents a 19.27% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Lori Anne Kunkel also recently made the following trade(s):

  • On Friday, June 5th, Lori Anne Kunkel sold 10,000 shares of Bitwise MARA Option Income Strategy ETF stock. The stock was sold at an average price of $34.54, for a total value of $345,400.00.

Bitwise MARA Option Income Strategy ETF Stock Up 0.1%

Shares of NYSEARCA IMRA traded up $0.01 during trading hours on Wednesday, hitting $15.69. The company had a trading volume of 6,145 shares, compared to its average volume of 5,168. Bitwise MARA Option Income Strategy ETF has a 1-year low of $11.99 and a 1-year high of $54.94. The firm’s 50 day moving average is $16.90 and its 200-day moving average is $15.58. The stock has a market capitalization of $2.04 million, a P/E ratio of 313.80 and a beta of 2.74.

About Bitwise MARA Option Income Strategy ETF

(Get Free Report)

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2?related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.

See Also

Insider Buying and Selling by Quarter for Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA)

Receive News & Ratings for Bitwise MARA Option Income Strategy ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bitwise MARA Option Income Strategy ETF and related companies with MarketBeat.com's FREE daily email newsletter.